Thomas Wilke (T Wilke)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Patients With Inflammatory Bowel Disease

Ejection Fraction

Small Cell Lung Cancer

Top Venues

Future oncology (London, England)

International journal of chronic obstructive pulmonary disease

Therapeutic advances in gastroenterology

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) 20 (19) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Evi Zhuleku, Daniel Wirth, Riikka Nissinen, Ivana Bravatà, Despina Ziavra, Andreas Duva, Jennifer Lee, Andreas Fuchs, Sabrina Mueller, Thomas Wilke, Bernd Bokemeyer
Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis. Therapeutic advances in gastroenterology 17 (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data. Journal of medical economics 27 (1) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data. Journal of medical economics 27 (1) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) 20 (19) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) 20 (19) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Evi Zhuleku, Daniel Wirth, Riikka Nissinen, Ivana Bravatà, Despina Ziavra, Andreas Duva, Jennifer Lee, Andreas Fuchs, Sabrina Mueller, Thomas Wilke, Bernd Bokemeyer
Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis. Therapeutic advances in gastroenterology 17 (2024)
Frank Griesinger, Sreeram Ramagopalan, Winson Y Cheung, Thomas Wilke, Sabrina Mueller, Alind Gupta, Dylan E O'Sullivan, Paul Arora, Darren R Brenner, Carolin Froelich, Jessica Inskip, Ulf Maywald, Vivek Subbiah
Association between treatment and improvements in overall survival of patients with advanced/metastatic non-small cell lung cancer since 2011: A study in the United States, Canada, and Germany using retrospective real-world databases. Cancer (2023)
Fraence Hardtstock, Julia Krieger, Thomas Wilke, Marco Lukas, Bernhard Ultsch, Robert Welte, Renate Quinzler, Ulf Maywald, Hartmut Timmermann
Epidemiology, treatment and health care resource use of patients with severe asthma in Germany - a retrospective claims data analysis. The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Fraence Hardtstock, Julia Krieger, Thomas Wilke, Marco Lukas, Bernhard Ultsch, Robert Welte, Renate Quinzler, Ulf Maywald, Hartmut Timmermann
Use of Biologic Therapies in the Treatment of Asthma - A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation. Journal of asthma and allergy 15 (2022)
Evi Zhuleku, Beatriz Antolin-Fontes, Andras Borsi, Riikka Nissinen, Ivana Bravatà, Jennifer Norma Barthelmes, Manuela Le Bars, Jennifer Lee, Alun Passey, Ulf Maywald, Barthold Deiters, Bernd Bokemeyer, Thomas Wilke, Marco Ghiani
Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn's Disease patients: A retrospective analysis using German claims data. Therapeutic advances in gastroenterology 15 (2022)
Marco Ghiani, Ulf Maywald, Thomas Wilke, Bart Heeg
Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data. Journal of comparative effectiveness research 11 (7) (2022)
Thomas Wilke, Hartmut Timmermann, Sabrina Mueller, Fraence Hardtstock, Victoria Unmuessig, Robert R Welte, Ulf Maywald
Association between asthma control and healthcare costs: Results from a German linked data study. Health services management research (2022)
Thomas Wilke, Burkhard Weisser, Hans-Georg Predel, Roland E Schmieder, Sven Wassmann, Anton Gillessen, Jörg Blettenberg, Ulf Maywald, Olaf Randerath, Sabrina Müller, Michael Böhm
Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany. Journal of comparative effectiveness research 11 (6) (2022)
Sabrina Müller, Tjalf Ziemssen, Curt Diehm, Tobias Duncker, Philipp Hoffmanns, Inga-Marion Thate-Waschke, Markus Schürks, Thomas Wilke
How to Implement Adherence-Promoting Programs in Clinical Practice? A Discrete Choice Experiment on Physicians' Preferences. Patient preference and adherence 14 (2020)
Fraence Hardtstock, Urbano Sbarigia, Zeki Kocaata, Thomas Wilke, Shirley V Sylvester
Preferences of Patients with Chronic Hepatitis B - A Discrete Choice Experiment on the Acceptability of Functional Cure. Patient preference and adherence 14 (2020)
Bernd Bokemeyer, M Ghiani, A Fuchs, Barthold Deiters, Fraence Hardtstock, A Brandes, J Knop, Hans-Dieter Orzechowski, Thomas Wilke
Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting. International journal of colorectal disease 35 (8) (2020)
Birgit Terjung, Renate Schmelz, Robert Ehehalt, Jochen Klaus, Jana Knop, Sabine Schwind, Thomas Wilke, Andreas Stallmach
Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review. Therapeutic advances in gastroenterology 13 (2020)
Sabrina Mueller, Thomas Wilke, Vanessa Gorasso, Marc Erhart, Jens M Kittner
Adaption and validation of the adherence barriers questionnaire for HIV patients on antiretroviral therapy (ABQ-HIV). BMC infectious diseases 18 (1) (2018)